Finance committee  Good afternoon. I'd like to begin by thanking the committee for the opportunity to be here today. As was mentioned, my name is Allan Rewak and I am the executive director of the Cannabis Council of Canada, or C3. We serve as the national trade association for producers of medici

Finance committee  Absolutely, and I'd like to provide some clarification, respectfully, to that investment and those shady investors that are referred to. The money that was often quoted in le Journal de Montréal was related to offshore trusts. These are created for a variety of reasons, generall

Finance committee  As we scale up, that's a very ambitious target. The United States is not an accurate comparator. Our high regulation of production is a little different from the way they do it. We have added costs. That said, as we scale up, there will be a reduction in price over time. But to

Finance committee  Much of this is anecdotal. Unfortunately, we just don't know because we don't have the systems fully in place. Supply agreements are still being formed and adult consumer use sales networks are being finalized. What I can say in a generalized fashion is that I would anticipate m

Finance committee  No data is available that indicates that to my knowledge. At the end of the day this is a very different product category. Consumers will choose to use it. There is a lower incidence of harm, a lower rate of addiction, a lower risk of car accidents, etc. Respectfully, the compari

Finance committee  Good afternoon. Thank you very much for the opportunity to be here today. As mentioned, my name is Allan Rewak, and I am the executive director of Cannabis Canada, the national trade association for licensed producers of medical cannabis under the ACMPR. Our group has recently